Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07518264Not ApplicableActive Not Recruiting

Efficacy and Underlying Mechanisms of Group-Based Natural Psychotherapy for Anxiety Disorder

Role: collaborator

NCT06843824Not ApplicableCompleted

A Graphene Far-infrared Intervention Study of Cognitive Status in Older Adults

Role: lead

NCT07161986Not ApplicableCompleted

Mapping And Preventing Relapse Risk in Polydrug Users

Role: lead

NCT06346496Not ApplicableCompleted

Young People Aged 18-25 With Depression or Anxiety Mood Participate in an LLM-based Digital Dialogue Intervention Study

Role: lead

NCT06213220Unknown

Wearable Devices System Diagnoses Mood Disorder in Children and Adolescents

Role: lead

NCT06181747Not ApplicableCompleted

Development of Attention and Its Relationship With Emotions in Children and Adolescents

Role: lead

All 6 trials loaded